Abstract
Antitrypsin is the predominant protease inhibitor in human plasma. Despite its name, its prime function is an inhibitor of neutrophil elastase. It is the archetype of a family of protease inhibitors (serpins) characteristically with a MW 50,000 and a highly ordered tertiary structure. Its role is as a protector of vulnerable tissues against digestion by leukocyte enzymes, and plasma deficiency predisposes to premature emphysema. Northern Europeans are uniquely susceptible to deficiency due to the frequency of two mutants (Z & S) both having substitutions at glutamic acids that form key salt bridges in the molecule. In the reactive center of antitrypsin is a labile methionine which allows leucocytes to switch off inhibitory activity but this contributes to the accelerated lung degeneration in cigarette smokers. Although plasma replacement therapy is one option for treatment a first approach is to avoid smoking and other environmental irritants.
Similar content being viewed by others
References
Boswell DR, Carrell RW (1986) Clinical aspects of the serpins: a family of plasma protease inhibitors. Rec Adv Clin Immunol 4:16
Brantly M, Nukiwa T, Crystal RG (1988) Molecular basis of alpha-1-antitrypsin deficiency. Am J Med 84:13–31
Carrell RW (1986)α-Antitrypsin: molecular pathology, leukocytes and tissue damage. Perspectives. J Clin Invest 78:1427–1431
Carrell RW, Aulak KS and Owen MC (1989) The molecular pathology of the serpins. Mol Biol Med 6:35–42
Cox DW, Woo SLC, Mansfield T (1985) DNA restriction fragments associated withα 1-antitrypsin indicate a single origin for deficiency allele PI Z. Nature 316:79–81
Loebermann TR, Deisenhofer J, Huber R (1984) Human alpha-1-proteinase inhibitor: crystal structure analysis of two crystal modifications, molecular model and preliminary analysis of the implications for function. J Mol Biol 177:531–556.
Travis J, Salvesen GS (1983) Human plasma proteinase inhibitors. Annu Rev Biochem 52:655–709
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Carell, R.W. The molecular structure and pathology ofα 1-antitrypsin. Lung 168 (Suppl 1), 530–534 (1990). https://doi.org/10.1007/BF02718175
Issue Date:
DOI: https://doi.org/10.1007/BF02718175